Irreversible inhibitors of G12C mutant K-Ras protein are provided. Also disclosed are methods to modulate the activity of G12C mutant K-Ras protein and methods of treatment of disorders mediated by G12C mutant K-Ras protein.
In SbF5–HF, para-alkylated or 2,6-dialkylated phenols (and their ethers) react with bromine to give the corresponding meta-bromo-substituted compounds; the mechanism implies bromination of the O-protonated substrate.
CATALYSTS, PROCESSES FOR MAKING CATALYSTS, PROCESSES FOR MAKING POLYOLEFIN COMPOSITIONS, AND POLYOLEFIN COMPOSITIONS
申请人:Kuhlman Roger L.
公开号:US20100227990A1
公开(公告)日:2010-09-09
The present invention relates to compositions and processes of making catalysts and polyolefins. More particularly, the invention relates to snap shut catalysts, processes for making the catalysts, processes for making polyolefins using the catalysts and the polyolefins resulting therefrom.
Catalysts, processes for making catalysts, processes for making polyolefin compositions and polyolefin compositions
申请人:Dow Global Technologies LLC
公开号:EP2757113A2
公开(公告)日:2014-07-23
The present invention relates to compositions and processes of making catalysts and polyolefins. More particularly, the invention relates to to snap shut catalysts, processes for making the catalysts, processes for making polyolefins using the catalysts and the polyolefins resulting therefrom.
Combination therapies for treatment of cancers associated with mutations in the KRAS gene are provided. Compositions comprising therapeutic agents for treatment of cancers associated with mutations in the KRAS gene are also provided.